JOHNSON DAVID LEE

CIK 00017338833 companiesBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001733883

Recent Transactions

50 trades

Award
Caribou Biosciences, Inc.$CRBU
Option to purchase Common Stock
2025-02-20+40,500→ 40,500 total
Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2025-02-18+53,800→ 53,800 total
Award
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2025-02-18+26,900→ 26,900 total
Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2024-07-01+160,000→ 160,000 total
Award
Caribou Biosciences, Inc.$CRBU
Option to purchase Common Stock
2024-02-20+39,500→ 39,500 total
Award
Caribou Biosciences, Inc.$CRBU
Option to purchase Common Stock
2023-02-21+21,500→ 21,500 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−55,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−34,384→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−3,125→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−10,935→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−13,814→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−26,454→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−15,460→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−42,400→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−28,628→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−38,739→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−38,500→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−40,000→ 0 total
Gift
Global Blood Therapeutics, Inc.
Common Stock
2022-09-28−22,000→ 34,384 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−2,208→ 15,460 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−2,763→ 13,814 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+2,208→ 58,487 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01$68.15/sh−2,103→ 56,384 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+2,763→ 56,279 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2022-08-31$25.37/sh+365→ 53,516 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-08-01+6,770→ 55,493 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-08-01−3,645→ 10,935 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-08-01−3,125→ 3,125 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-08-01$32.40/sh−2,342→ 53,151 total
Award
Caribou Biosciences, Inc.$CRBU
Option to purchase Common Stock
2022-05-18+44,000→ 44,000 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-04-01−4,375→ 0 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-04-01$35.91/sh−1,513→ 48,424 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-04-01+4,375→ 49,937 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
2022-03-01+28,628→ 28,628 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-03-01+2,763→ 46,518 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-03-01$29.87/sh−956→ 45,562 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01−2,763→ 16,577 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01+17,668→ 17,668 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01+17,668→ 17,668 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2022-02-28$25.37/sh+472→ 43,755 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-02-01$29.33/sh−2,559→ 43,283 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-02-01+6,770→ 45,842 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-02-01−3,645→ 14,580 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-02-01−3,125→ 6,250 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2021-10-01+4,375→ 41,242 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-10-01−4,375→ 4,375 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2021-10-01$26.25/sh−2,170→ 39,072 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-09-01−2,762→ 19,340 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2021-09-01+2,762→ 37,939 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2021-09-01$29.85/sh−1,072→ 36,867 total

Companies

Recent Filings

Address

C/O VERA THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 1200

BRISBANE, CA, 94005

View on SEC.gov